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ABSTRACT 
 RNA Polymerase II (Pol II), the enzyme that transcribes all messenger 
RNAs (mRNAs), has another activity by pausing at gene promoters. The paused 
Pol II generates short 5’-capped RNAs of about 50 nucleotides in length. Much is 
known about Pol II pausing including its prevalence across the genome, but the 
molecular mechanisms that are involved in regulating Pol II pausing and its roles 
in gene regulation are yet to be fully explored. In this study, I have investigated 
the molecular mechanisms that regulate dynamics of Pol II pausing in response 
to gene activation.  
 The main goal of this study was to determine how cells respond to stimuli 
by altering Pol II pausing states. To this end, we characterized changes in Pol II 
pausing in MCF-7 human breast cancer cells using two distinct stimuli, heat 
shock and Trichostatin A (TSA), a histone deacetylase inhibitor. Two genes, 
SNAI1, a master regulator of epithelial to mesenchymal transition, and HSPA1B 
(heat shock protein 70), a master regulator of heat shock response, show mRNA 
upregulation upon treatment with both stimuli. To determine changes in Pol II 
pausing and its dynamics in response to gene activation, I have used 
permanganate footprinting for single gene analysis, and short-capped RNA 
sequencing (scRNA-seq) for genome-wide analysis. I have shown that, upon 
activation, paused genes can retain Pol II pausing and non-paused genes can 
acquire Pol II pausing. Further, I observe that genes such as HSPA1B undergo 
 xvi 
pause release during heat shock activation but SNAI1 does not. In addition, I 
have shown that the turnover of the paused Pol II complex changes in a 
stimulus-specific manner, indicating that the release of paused Pol II is sensitive 
to the nature of the stimulus. To investigate the rate of turnover of the paused 
complex, I used a specific inhibitor of a general transcription factor TFIIH, 
Triptolide, and measured the residence time of the Pol II complex at the paused 
site. Genome-wide analysis of Pol II turnover demonstrates that not all genes 
respond the same way to heat shock. This project describes a novel mechanism 
for regulation of transcription during gene activation in human cells in response to 
environmental stresses. 
 1 
CHAPTER I 
INTRODUCTION 
1.1 Eukaryotic Transcription 
 Gene expression in eukaryotes is a tightly controlled, complex process 
regulated by numerous transcription factors and enzymes. Chromatin-associated 
proteins such as histones and non-histone proteins are involved in compacting 
the genome, which is about 2m long in humans, into a confined space in the 
5 μM nucleus. Dynamic interactions of chromatin with a variety of cellular factors 
such as histone modifying enzymes and histone chaperones, ATP dependent 
chromatin remodelers, activate and/or repress gene expression.  
 Eukaryotic transcription is a precisely timed process where multiple 
proteins come together to synthesize RNA from appropriate genes. All 
messenger RNA (mRNA) in eukaryotes are transcribed by the multi-subunit 
enzyme RNA Polymerase II (Pol II). Transcription by Pol II occurs via three major 
steps: transcription initiation, elongation and termination. Recruitment of Pol II to 
promoters (transcription initiation) was long considered as the main regulatory 
step of transcription in higher organisms. 
1.2 Transcription Initiation 
 Transcription is initiated at the promoter DNA elements, which involves 
sequential binding of general transcription factors (GTFs), TFIIA, TFIIB, TFIID, 
TFIIE, TFIIF, and TFIIH (Matsui et al. 1980), together with Pol II, forming the 
 2 
pre-initiation complex (PIC) (Figure 1). The formation of PIC is also dependent on 
chromatin remodeling, which involves modifications of histones in the promoter 
region (Kadonaga 2004). It has been suggested that histone modifications and 
other chromatin marks play a regulatory role in highly transcribing genes (Vakoc 
et al. 2005). The binding motifs of GTFs promote the assembly of the PIC by 
facilitating DNA-protein and protein-protein interactions. Once the PIC is 
established, Pol II together with other transcription factors (Pol II complex) can 
proceed with transcription. There are multiple events during early transcription 
that play regulatory roles. Pausing of Pol II and premature termination of 
transcription in promoter-proximal regions are two of such steps that will be 
discussed later in this chapter. 
 
 
Figure 1.  A schematic diagram showing an overview of transcription. Pol II 
gets recruited on to the promoter region along with other general 
transcription factors to initiate transcription. Transcription is initiated 
at the transcription start site (TSS), indicated by a black arrow. After 
transcribing about 50 nucleotides from the TSS, Pol II pauses thus, 
producing a short capped RNA. Once paused, Pol II can proceed 
into elongation. During the elongation step the mRNA molecule 
gets synthesized. Once the Pol II complex reaches the transcription 
end site (TES), it undergoes termination dissociating from the DNA 
template and releasing the mRNA molecule.  
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1.3 Elongation 
 Apart from initiation, elongation also plays a critical step in gene 
regulation. The carboxyl terminal domain (CTD) is the largest subunit of Rpb1, 
the largest subunit of Pol II, undergoes extensive modification during elongation. 
The CTD contains tandem heptad repeats of a consensus sequence of amino 
acids -YSPTSPS that is evolutionary conserved across eukaryotes. Yeast has 24 
repeats on the CTD of Pol II whereas humans have 52 repeats. The serine 
residues of the CTD remain unphosphorylated during recruitment but undergo a 
series of modifications post recruitment or Pol II to the promoter. The serine-5 
residues on CTD are phosphorylated by the cyclin dependent kinase 7 (CDK7), a 
subunit of TFIIH, during early elongation and pausing. Serine-5 phosphorylation 
is assumed to destabilize the interaction of Pol II with promoter elements and 
enhance the interactions with elongation factors, facilitating elongation. Transition 
of the Pol II complex to active elongation occurs with the recruitment of the 
kinases that phosphorylate the serine-2 residues on CTD. The serine-2 
phosphorylated-elongating Pol II complex is capable of recruiting factors that are 
involved in chromatin remodeling and mRNA processing (Peterlin et al. 2006). 
The transition of the Pol II from paused state to the elongating state requires the 
kinase activity of p-TEFb (Marshall and Price 1992, Marshall and Price 1995). A 
second kinase comprised of cyclin K and Cdk12 or Cdk13 is also involved in 
phosphorylation of CTD in the 3’-end of the gene (Bartkowiak et al. 2010; 
Greifenberg et al. 2016). Hence, phosphorylation of the CTD plays a role in 
determining the status of Pol II complex during transcription.  
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 Another feature that changes along the gene body is the Pol II elongation 
rate. The correlation between characteristics of the gene body and the rate at 
which the polymerase is able to move through the gene has been extensively 
studied. Elongation rates have been measured to be ranging from 1-4 kilobases 
per minute (Ardehali et al. 2009; Hah et al. 2011). The rate of transcription has 
been shown to vary depending upon the region of the gene: the elongation rate is 
slowest at promoter regions and is increased across the gene body (Danko et al. 
2013). A recent study showed clear differences in elongation rates in response to 
two different stimuli, TNF-α and Estradiol (E-2), and an increased Pol II signal 
was measured at exons. However, this study was unable to demonstrate a 
common trend in Pol II elongation rate in exons (Danko et al. 2013). In mouse 
mesenchymal stem cells, the elongation rate was found to be negatively 
correlating with CpG content and exon content and positively with the active 
transcription mark of H3K79me2 (Jonkers et al. 2014). This evidence highlights 
both pausing and elongation as steps that are clearly regulated during 
transcription.  
 Pol II elongation is tightly linked to chromatin modifications. For instance, 
the Pol II associated factor (PAF) complex is physically associated with 
elongating Pol II and recruits histone H2B ubiquitinating enzymes (Pokholok et 
al. 2002; Wood et al. 2003). Also, the histone chaperone Facilitates Chromatin 
Transcription (FACT) histone chaperone complex is required for nucleosome 
assembly and is involved in recruitment of p-TEFb (Saunders et al. 2003; Wada 
et al. 2000).  
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 The rate of Pol II elongation has been proposed to influence co-
transcriptional processes such as splicing (Howe et al. 2003; de la Mata et al. 
2003; Shukla & Oberdoerffer 2012), 3′ end processing (Nag et al. 2007) and 
termination (Hazelbaker & Buratowski 2012).  
1.4 Transcription Termination 
 After completion of mRNA synthesis, Pol II dissociates from DNA at the 
transcription end site (Figure 1). This final step in transcription allows recycling of 
Pol II molecules for new initiation events. Most eukaryotic genes carry a highly 
conserved poly A signal at their 3’ ends. Once the polymerase transcribes the 
poly A tail, the processivity of the enzyme reduces markedly. In humans, several 
complexes are known to facilitate transcription termination. The ser-2 hyper-
phosphorylated CTD of Pol II is involved in recruiting several protein complexes 
that facilitate transcription termination such as cleavage and polyadenylation 
specificity factor (CPSF), the cleavage stimulatory factor (CstF) and Poly (A) 
polymerase (Kuehner et al. 2011). Both CPSF and CstF complexes are recruited 
to predominantly ser-2 Phosphorylated CTD repeats of Pol II. In addition, CPSF 
has been shown to bind to AAUAAA, the mammalian Poly A signal, and slows 
down the Pol II complex to trigger termination of transcription at the 3’ termini of 
genes. Termination factors are found proximal to transcription end sites. 
However, recent studies have shown occupancy of such factors close to 
promoter proximal regions leading to exciting discovery of premature termination 
in promoter regions, which will be discussed in 1.7 (Figure 2). 
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Figure 2.  A scheme of pausing of RNA Polymerase II as a central 
mechanism in regulating gene transcription. The dashed arrows 
indicate the processes that occur at promoter proximal region. 
Once Pol II (red pentagon) is recruited and starts initiation (the solid 
black arrow indicates the transcription start site), it transcribed 
about 50 nucleotides and pauses at most mRNA gene promoters in 
the presence of NELF (blue). Once paused Pol II can either 
proceed into elongation (grey arrow) with the action of factors such 
as p-TEFb or dissociate from the DNA template undergoing 
premature termination in the presence of factors such as XRN2 
(brown). The short RNA and Pol II is dissociated from the DNA 
template during premature termination where Pol II can initiate 
more cycles of transcription. 
 
1.5 Processing of mRNA during Transcription 
 In eukaryotes, mRNA that is produced by Pol II undergoes several 
modifications. Most of these modifications occur co-transcriptionally and the 
three main processing steps are 5’ capping, splicing of introns and addition of a 
poly A tail at the 3’ end of the RNA.  
1.5.1 Capping of Pol II Transcripts 
 5’ capping is exclusive to transcripts of Pol II and is the first modification 
on the nascent mRNA. The cap structure is an essential feature of mRNA that 
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allows them to be recognized by translational machinery in the cytoplasm. During 
the early stages of transcription, the CTD domain of Pol II is hyper-
phosphorylated at the ser-5 residue. A 7-methylguanosine cap (7 mG) structure 
is added to the nascent mRNA soon after initiation, during the transcription of the 
first 25-30 nucleotides (Jove & Manley 1984; Rasmussen & Lis 1993) by 
recruitment of capping enzymes (McCracken et al. 1997). The process of 
capping of the 5’ end of the RNA is an intricate three step process (Mizumoto & 
Kaziro 1987).  
 In addition to 7 mG, multiple different cap structures have been observed 
predominantly on RNA that are much shorter, less than 200 nucleotides, than 
mRNA and also in virus RNAs. Some small nuclear RNA (snRNA) and small 
nucleolar RNA have been shown to contain a trimethylated version of the 7 mG 
cap structure; (2,2,7 mG) (Banerjee 1980). Some viral RNA species have been 
shown to contain 2,7 mG, a dimethylated cap structure (HsuChen & Dubin 1976). 
The capped structure has been shown to stimulate splicing of the nascent RNA 
in vitro (Konarska et al. 1984; Edery & Sonenberg 1985) and in vivo (Fresco & 
Buratowski 1996; Schwer & Shuman 1996). The capped structure recruits cap 
binding proteins (CBP) 20 and 80 that are involved in splicing and transport of 
mRNA to the cytoplasm. In addition, the capped structure can be recognized by 
protein synthesis machinery of the cell. 5’ capped RNA binds to translation 
initiation factor eIF4E, promoting translation (Sonenberg et al. 1978; Edery et al. 
1988; Fresco & Buratowski 1996). Further, antibodies against these specific cap 
structures can be used to immunoprecipitate the RNAs (Bochnig et al. 1987) that 
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can be subjected to microarray analysis or sequencing in downstream 
applications (Jia et al. 2007). The capped structure enables identifying transcripts 
of Pol II, which allows quantification of RNA through multiple methods including 
scRNA-seq (Nechaev et al. 2010; Samarakkody et al. 2015) and Pro-cap-seq 
(Kwak et al. 2013; Mahat et al. 2016). These genome-wide techniques allow 
visualizing Pol II transcription by specifically detecting RNAs that are protected at 
the 5’ end by a cap structure.  
1.5.2 Splicing 
 During transcription elongation, the intronic regions of the nascent RNA 
are removed and the exons are joined to generate a mature mRNA in a process 
termed splicing. Splicing allows extensive diversity of mRNA and proteins in a 
cell to arise from the same sequence of the gene (Wang et al. 2008; Warns et al. 
2016). About 95% of protein coding genes in the cell can undergo alternative 
splicing (Pan et al. 2008; Wang et al. 2008). Committed factors involved in 
splicing are recruited to perform co-transcriptional splicing of the nascent pre-
mRNA (Ardehali & Lis 2009) and this process involves extensive DNA-RNA, 
DNA-protein and RNA-protein interactions. General splicing factors and small 
nuclear ribonucleoproteins (snRNPs) interact with proteins that are specific to 
certain DNA sequences, to form a multisubunit complex, the spliceosome. The 
variations in splicing patterns are closely related to the chromatin architecture 
and elongation rate of Pol II along the gene body (de la Mata et al. 2003; Fong et 
al. 2014). Alternative splicing has been observed in many biological processes 
such as development, cancer (Srebrow & Kornblihtt 2006) and also during 
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cellular stresses (Pleiss et al. 2007). Large switching in splicing patterns during 
progression of cancer generates protein variants that function during changes in 
cell morphology and transcriptional programs (Warzecha & Carstens 2012). 
Among cellular stresses, splicing has been shown to be abolished in response to 
heat shock but not chemical stresses (Yost & Lindquist 1986; Bond 1988; 
Biamonti & Caceres 2009), and can be rescued by the presence of elevated 
levels of heat shock proteins (Yost & Lindquist 1986). Chemical stresses also 
induce heat shock proteins. However, the splicing patterns and mechanisms are 
vastly different between the two responses. The relations of variation in splicing 
with different stimuli to early transcriptional event are yet to be explored.  
1.5.3 Polyadenylation  
 Most mRNAs have a tail with multiple adenosine (A) residues at their 3’ 
termini, commonly referred to as the poly A tail. PolyA polymerase has been 
identified as the enzyme involved in adding A nucleotides to the 3’ termini 
(Darnell et al. 1971; Edmonds et al. 1971; Lee et al. 1971). Most mRNAs contain 
a highly conserves hexanucleotide sequence, AAUAAA, approximately 10-30 
bases upstream of the polyadenylation site. There’s a second GU-rich region, 
approximately 20-40 bases downstream of the transcription end site. These two 
sequences and the distance between them not only determine the site of poly A 
addition (MacDonald et al. 1994; Takagaki & Manley 1997), but also the length of 
the poly A tail (Chen et al. 1995). The poly A tail stabilizes the mature mRNA as it 
is transported to the cytoplasm to be translated. 
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1.6 Promoter Proximal RNA Polymerase II Pausing 
 Although recruitment of Pol II and formation of the PIC are essential 
regulatory steps in transcription, another major step of regulation of transcription 
is promoter proximal Pol II pausing. After transcribing about 50 nucleotides from 
the transcription start site, Pol II stalls generating a small RNA with a 5’ cap 
(Figure 2). Pausing was first characterized on heat shock proteins, mainly on 
HSP 70 of Drosophila melanogaster, when transcriptionally active polymerase 
was found within a narrow region at the gene promoter prior to the induction of 
the gene, immediately downstream of the transcription start site (Gilmour & Lis 
1986). Following this work, Pol II pausing was described in other cell lines 
derived from higher organisms and on other genes, implying that Pol II pausing is 
a widespread phenomenon among metazoans. Genome-wide studies on Pol II 
pausing in mammals and Drosophila (reviewed in Adelman & Lis 2012) have 
indicated that pausing occurs specifically at genes involved in developmentally 
related pathways (Muse et al. 2007; Levine 2011), stimulus response, 
maintenance of pluripotency and more recently at many metabolic genes 
(Williams et al., 2015). Even though the exact biological function of Pol II pausing 
remains largely unknown, its importance in regulating gene expression is no 
longer questioned. Others have shown that Pol II may compete with the 
nucleosome at the +1 position to maintain the promoter in an open configuration 
(Gilchrist et al. 2008). Some alternative hypotheses that have been proposed are 
that pausing functions as a checkpoint for the 5’ end processing of RNA and also 
ensures proper formation and modifications on the Pol II complex itself (Adelman 
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& Lis 2012). Promoter proximal pausing of Pol II has been shown to accompany 
histone H3K4me3 in embryonic stem cells, implying the association of pausing 
with active genes (Chopra et al. 2011). 
 A number of different factors have been identified to regulate various 
stages of pausing such as establishment of pausing, escape of pausing and 
more recently premature termination of paused Pol II complexes. The transition 
from the paused state to productive elongation is closely related to the changes 
in phosphorylation status of the CTD of the largest subunit of Pol II.  
1.7 Regulation of RNA Polymerase II Pausing 
 Pol II pausing peaks between 35-50 nts from transcription start sites in 
Drosophila (Nechaev 2010), mouse (Core 2014) and human (Samarakkody et al. 
2015) cells (Figure 2). The similarity in the location of paused Pol II in different 
systems implies conservation of pausing location across species. The biological 
systems that are being employed have vast differences in promoter sequences. 
Hence, an obvious question of the sequence dependency of Pol II pausing is not 
supported by much evidence in human systems. Transgene experiments in  
Drosophila identified both the distal and proximal regions of the Hsp70  gene as 
promoting Pol II pausing and mutations in those sequences decreased levels of 
paused Pol II (Lee et al. 1992). Mammalian genes display prominent regions of 
repetitive CG nucleotides, also known as CpG islands, around their promoter 
regions, whereas Drosophila genes lacks such a feature (Hoskins et al. 2011). 
The presence of CpG islands brings in diverse proteins and protein complexes 
that are involved in DNA methylation at the cytosine nucleotides of a CG pair. 
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DNA methylation brings about changes in promoter architecture; deacetylation of 
histone H4 and methylation of histone H3 Lysine 9 (Hashimshony et al. 2003). 
Such changes in chromatin structure cause Pol II pausing to be different in 
promoter regions across species (Core et al. 2008; Rozenberg et al. 2008). The 
conservation of location of Pol II pausing across species is a consequence of 
multiple regulatory proteins and complexes that act at promoter proximal regions 
of genes irrespective of the DNA sequence. Among the most important problems 
is to understand how factors involved in Pol II pausing, elongation and premature 
termination integrate to produce a specific outcome; either a mature mRNA 
through productive elongation or short transcript through termination. 
Collectively, the ability of paused Pol II to take two routes makes it, potentially, a 
decision-making point of gene expression during early elongation. The question 
remains whether pausing at steady state is a rigid property of a gene or a 
dynamic property reflective of a cell state.  
1.7.1 Establishment of Pol II Pausing through  
Negative Elongation Factor (NELF) 
 
 Pausing at promoter regions is enforced by two multisubunit complexes: 
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) sensitivity-inducing factor 
(DSIF), which contains Spt4a and Spt5, and negative elongation factor (NELF, 
containing subunits A-E). These two complexes bind through C/D subunits of 
NELF complex (Sun and Li, 2010). The five subunits of the NELF complex are 
thought to act synergistically since depletion of individual subunits leads to 
diminished levels of the others (Gilchrist et al. 2008; Sun and Li, 2010). The E 
subunit of the NELF complex contains arginine-aspartic acid dipeptide repeats 
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and has been shown to directly interact with RNA (Yamaguchi et al. 2002). A 
more recent study showed that the NELF complex may have at least 3 different 
RNA-binding domains (Vos et al. 2016), which may enable NELF to facilitate 
exchange of different RNA species competing either directly with each other or 
acting allosterically. Interaction of NELF with enhancer RNA (eRNA) has been 
shown to promote its release on early response genes and trigger release of 
paused Pol II into elongation (Schaukowitch et al. 2014).  However, 
understanding of the functions of NELF and eRNA is limited thus far.  
 NELF is an essential factor and its depletion has shown to be 
embryonically lethal (Amleh et al. 2009). In vitro, NELF does not appear to bind 
to Pol II or DSIF alone but it is able to bind the Pol II-DSIF complex (Yamaguchi 
et al. 2002). Apart from the DRB complex, subunits of NELF has been shown to 
interact with multiple proteins and complexes in the nucleus such as the cap 
binding complex (CBC) of RNA (Narita et al. 2007) and the NELF-B subunit has 
been shown to associate with breast cancer susceptibility gene BRCA1 (Ye et al. 
2001).  
 Given the role of NELF in inducing Pol II pausing, depletion of NELF is 
expected to increase expression of genes due to removal of pausing as a 
roadblock. However, studies show that depletion of NELF, contrary to 
expectations, leads to decreased expression of many genes in Drosophila, 
mouse and human systems (Gilchrist et al. 2008; Rahl et al. 2010; Sun & Li 
2010). Moreover, NELF depletion decreases stability of paused Pol II (Henriques 
et al. 2013), yet these complexes do not go into productive elongation in most 
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genes (Core et al. 2012). NELF depletion in Drosophila cells was shown to affect 
recovery from heat shock (Ghosh et al. 2011). Thus, NELF, or pausing, clearly 
have roles other than gene repression, and remain to be investigated. 
1.7.2 Escape of Pausing into Elongation:  
Positive Transcription Elongation Factor b 
 
 Positive elongation factor b (p-TEFb) alleviates the transcription halt 
caused by of DSIF and NELF by phosphorylating them and allowing Pol II to 
enter into elongation (Figure 2) (Renner et al. 2001; Yamaguchi et al. 1999). p-
TEFb is a protein kinase that targets phosphorylation of ser-2 residues of Pol II 
CTD (Price 2000) and is comprised of cyclin dependent kinase 9 (Cdk9) and 
either Cyclin T1 (CycT1), Cyclin T2 (CycT2) or Cyclin K (CycK). p-TEFb is 
sequestered by the evolutionary conserved non-coding RNA, 7SK small nuclear 
RNA (snRNA) where the p-TEFb binding to the noncoding RNA is mediated by 
HEXIM1 or HEXIM2, and the formation of this complex inhibits the kinase activity 
of p-TEFb, thereby limiting the transition of promoter proximally paused Pol II into 
productive elongation. There are a number of factors that modulate Pol II pausing 
by regulating the localization of p-TEFb on a gene. Regulated release of p-TEFb 
has been shown to modulate global control of cell growth, proliferation and cell 
differentiation (He et al. 2006). A Yamanaka factor c-myc, an essential factor in 
embryonic stem cell renewal and proliferation(Cartwright et al. 2005), has been 
shown to bind p-TEFb in tumor cells (Gargano et al., 2007; Kanazawa et al., 
2003), and is involved in pause release, thus acting as a transcriptional activator 
(Rahl et al. 2010). NF-kB is another transcriptional activator that recruits p-TEFb 
to genes. Bromodomain containing protein 4 (BRD4) acts as an upstream 
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activator by mediating the acetylated histone dependent recruitment of p-TEFb 
(Gregoire & Yang 2005) to gene promoters. In addition, factors such NF-κB and 
c-myc that act primarily on initiation, have been found to promote pause escape 
into productive elongation (Barboric et al. 2001; Rahl et al. 2010). 
 In multiple previous studies, p-TEFb has been inhibited using small 
molecule inhibitors including DRB (Chodosh et al. 1989) and Flavopiridol (FP). 
FP is a highly potent inhibitor of CDK9 (Chao & Price 2001; Ni et al. 2004) that 
leads to overall suppression of transcription genome-wide (Ni et al. 2008; 
Jonkers et al. 2014) and increase in promoter proximal Pol II in majority of genes 
(Henriques & Adelman 2013).  
1.7.3 A Second Exit for Paused Pol II: Premature Termination 
 Once paused, instead of proceeding into elongation, Pol II complex can 
dissociate from the DNA template, terminating transcription abruptly (Figure 2). 
This premature termination of transcription yields a very short RNA transcript that 
is less than 100 nucleotides in length. With emerging evidence of occurrence of 
premature termination in biological systems, the molecular mechanisms and the 
action of candidate cofactor are still being unraveled. Recent studies have shown 
evidence of premature termination of transcription at the promoter proximal 
regions in yeast (Terzi et al. 2011), in an HIV model  (Wagschal et al. 2012) and 
in human cell lines (Brannan et al. 2012). The mechanisms described in the 
studies are not similar, which suggests that premature termination may be an 
inherent feature of a promoter. For example, the Nrd1-Nab3-Sen1 termination 
pathway described in yeast indicates that H3K4 trimethylation promotes 
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termination. Other studies describe how termination factors such as TTF2 and a 
5’ to 3’ exoribonuclease XRN-2 are recruited to promoter-proximal regions of 
genes to initiate termination. Consistent with a functional connection between 
termination and promoter proximal pausing, NELF has been shown to promote 
recruitment of a factor PCF11, another termination factor, to promoter-proximal 
regions in Human Influenza Virus (HIV (Natarajan et al. 2013). Taken together, 
premature termination likely involves distinct molecular mechanisms that can act 
through multiple proteins. How termination pathways are regulated during gene 
activation remains to be explored.  
1.8 Pause Duration 
 The conservation of location of Pol II pausing implies that similar 
mechanisms are involved in determining the dynamics of Pol II pausing. DSIF, 
NELF and p-TEFb have been identified to play a role in determining the 
residence time of Pol II at the paused site, which is an important measure of 
gene or promoter activity. Recent work suggests that additional factors, such as 
Gdown1, the product of the POLR2M gene that renders Pol II responsive to 
Mediator, and the general transcription factor TFIIF may also influence the pause 
duration of the paused polymerase. These factors act by affecting the 
vulnerability of the paused Pol II complex to undergo premature termination 
(Cheng et al. 2012). Therefore, pause duration recapitulates the action of the 
factors that are involved in maintaining and releasing paused Pol II. Yet, the 
underlying molecular mechanisms remain unclear. 
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 To determine the residence time of the paused Pol II complex, the small 
molecule inhibitor, Triptolide (TRP), has been used. TRP is an XPB/TFIIH 
inhibitor (Titov et al. 2011) that prevents the generation of newly engaged Pol II 
during transcription initiation by inhibiting melting of the DNA template. A time 
course of TRP treatment enables determination of the half-life of the paused Pol 
II complex. Published work has used a variety of methods such as Chromatin 
Immunoprecipitation (ChIP) Sequencing (ChIP-seq), Global run-on sequencing 
(Gro-seq), high resolution permanganate footprinting and optical imaging. The 
pause duration of Hsp70 gene on Drosophila polytene chromosomes was 
estimated at 5 minutes using an optical method. The strategy involved a GFP-
tagged Pol II and mCherry LacI bound Hsp70 transgene (Buckley et al. 2014). In 
mouse embryonic stem cells the pause duration averaged at 7 minutes (Jonkers 
et al. 2014). In another study in Drosophila S2 cells, pause duration was 
estimated for 12 genes where the pause duration exceeded 15 minutes on some 
genes (Henriques et al., 2013). A recent study using HCT116 cells showed that 
some genes, when treated with low TRP concentration, had prolonged pause 
duration, which exceeded one hour in the case of some genes like the early 
response gene FOS (Chen et al. 2015). The functional significance of Pol II 
pausing is to allow sufficient time to integrate regulatory inputs into transcription 
and (Henriques et al., 2013) allowing proteins to interact and undergo post 
transcriptional modifications. 
 The above-described dedicated factors help determine how fast Pol II is 
transitioning through promoter regions. The activity of such factors causes 
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alterations in pause duration. For example, absence of NELF causes direct 
reduction in pause duration that enable fast promoter escape of upregulated 
genes (Gilchrist et al. 2008). How these factors integrate during rapid cellular 
responses, such as stress and other environmental stimuli, to enable survival of 
the cell remains to be understood.  
1.9 Research Direction 
1.9.1 Transcriptional Responses during Cellular Stresses 
 Cellular responses to stress are evolutionarily ubiquitous and play 
essential roles in survival of the cell and the organism (Lindquist 1986; Feder & 
Hofmann 1999).  A cell can be exposed to many stresses from the environment 
such as osmotic pressure, change in pH, change in temperature, availability of 
nutrient content and heavy metals etc. Such suboptimal conditions trigger 
responses such as modifications on enzymes, alteration in metabolism, vesicular 
trafficking but one of the most upstream effects is change in gene expression. 
Gene expression changes are associated with changes in chromatin 
architecture; changes in nucleosome structure and positioning, regulation of 
specific transcription factors, and activation or repression of transcription on 
specific genes.  
 A cell responds to stress by activation of specific stress response 
pathways through activity of transcription factors and upregulation of specific 
genes. The ability to change specific biological pathways in response to stimuli 
enhances the chance of survival of a cell. Defects in various stress response 
pathways have been shown to associate with diseases such as cancer, diabetes 
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(Oyadomari et al. 2002), Alzheimer’s disease (Terro et al. 2002), Parkinson’s 
disease (Imai et al. 2001), etc. Defects in the heat shock response pathway 
compromised early development in mice (Xiao et al. 1999), and overexpressing 
the heat shock transcription factor in Caenorhabditis elegans results in increased 
longevity (Garigan et al. 2002; Lund et al. 2002). 
1.9.2 Gap in Knowledge 
 The dynamics of pausing and pause release remains largely unknown. It 
is intriguing to look into the dynamics of pausing and pause escape of the Pol II 
complex specifically during rapid transcriptional responses. This will determine if 
the molecular mechanisms involved are common across the genome, or if they 
are gene specific. While multiple studies have shown pausing and pause 
duration to possibly be gene specific, the mechanisms involved in such 
regulation remain to be characterized. In this study, I have explored pausing and 
pause duration in MCF-7, a human breast cancer cell line, in response to two 
activating signals, Trichostatin A (TSA) and heat shock. TSA is a compound that 
has been shown to upregulate mRNA expression of the SNAIL gene (SNAI1) in 
MCF-7 cells. SNAI1 is a master regulatory gene that is important in epithelial to 
mesenchymal transition (EMT). In addition, I have used SLUG (SNAI2) and E-
cadherin (CDH1) genes which are also involved in EMT. The second activator, 
heat shock, has been extensively used in the field, as it was the first system 
where Pol II pausing was first observed. This is the first time two activators were 
tested on the same gene and further, the first time that dynamics of two genes 
are compared in the same cells. 
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1.9.3 EMT 
 EMT is a common biological process that occurs during embryonic 
development. During EMT cells migrate during several major milestones in 
development including gastrulation and neural crest formation where epithelial 
cells transition to a more mesenchymal morphology. During EMT, vast changes 
occur in the extracellular matrix, plasma membrane and cell morphology. During 
EMT, matrix metalloproteinases that degrade the extracellular matrix and cell 
surface proteins leading to release of promigratory factors making cells more 
migratory and invasive (Derycke & Bracke 2004). The major characteristic of 
EMT is loss of the cell junction protein CDH1 on the plasma membrane. SNAI1 
has been described as a repressor of multiple target genes in human and non-
human cells lines including cancer cells. In human cancer stem cells, SNAI1 is 
shown to regulate the expression of a number of genes including IL-8 to induce 
metastasis in cells (Hwang et al. 2011). Overexpression of SNAI1 has been 
associated with recurrence of breast cancer (Moody et al. 2005) and hence much 
attention is drawn towards SNAI1 to understand its role in cancer metastasis.  
 In addition to its effects on chromatin, TSA has been reported to increase 
reactive oxygen species in a cell via kinase pathways (Rosato et al. 2003; Ruefli 
et al. 2001). Moreover, TSA is known to activate several signaling pathways that 
induce cellular stress such as NF-κB, MAPK and PI3K (Mayo et al. 2003; Ozaki 
et al. 2006; Yu et al. 2007; Ruefli et al. 2001). Taken together, TSA may act as 
an agent that induces cell stresses following short-term treatment. 
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1.9.4 Heat Shock Response 
 The specific protein factors that are involved in heat shock response 
(HSR) are broadly studied. HSR is an essential part of cell homeostasis that 
ensures cell survival. Upregulation of heat shock genes provides the cell with 
temporary enhanced tolerance to stress (Lindquist 1986; Sørensen et al. 2003). 
HSR is regulated by transcription factors heat shock factors (HSF). Vertebrates 
have 4 transcription factors HSF1-4, but HSF-1 is considered the master 
regulator of heat shock response. During HSR, HSF-1 trimerizes and binds to the 
heat shock element (HSE) in the promoter region of genes such as Hsp70 which 
results in gene upregulation by increasing promoter proximal pause release 
(Mahat et al. 2016).  
 The key to transcriptional activation during HSR is the association of  
p-TEFb with HSF-1 (Lis et al. 2000). Not all genes are activated in a HSF-1 
dependent manner during heat shock. Hence, an interesting question would be if 
genes that are activated by HSF-1 dependent and independent pathways show 
different dynamics of pausing at gene promoters. More specifically, changes in 
rates of premature termination and elongation are affected during gene activation 
will be reflected in measurements of pause duration. Therefore, using pause 
duration as a measurement we can determine if the mechanisms that act at the 
pause site are global or specific to a cohort of genes. Secondly, we will be able to 
determine if premature termination and escape into elongation act on the same 
genes in a stimulus specific manner.  
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1.9.5 Research Goal 
 The regulatory importance of Pol II pausing is not questioned in the field. 
Yet, the roles that paused Pol II plays during transcriptional responses remain to 
be explored. Many proteins are being identified as playing a role in Pol II 
regulation, but how these proteins contribute to produce specific transcriptional 
outcomes is still understudied.  
 In this study, I have first investigated levels of Pol II pausing on genes 
during basal and activated conditions in response to two stimuli, TSA and heat 
shock, in MCF-7 cells. Secondly, I have looked at Pol II pausing duration as a 
measure of dynamics of the paused Pol II complex during gene activation to 
determine if the molecular mechanisms that are involved during gene activation 
are common among genes. Finally, using sc-RNA sequencing I have 
investigated levels of Pol II pausing and changes in pause duration genome-wide 
to determine the global dynamics of Pol II pausing upon gene induction. 
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CHAPTER II 
MATERIALS AND METHODS 
2.1 Cell Culture and Treatments 
 The cell line used in this study, MCF-7, is a human breast cancer cell line 
derived from a metastatic site by pleural effusion of a 65 year old female. MCF-7 
cells were obtained from American Type Culture Collection (ATCC® HTB-22™) 
and were cultured in DMEM/F-12 medium (Life Technologies) with 10% fetal 
bovine serum (Gibco). The growth medium was replaced every three days. Cells 
were maintained in a humidified incubator at 37οC and 5% CO2.  
 Heat shock was carried out at 42οC for 30, 60 and 120 minutes. Cells 
were treated with Trichostatin A (Sigma) at a final concentration of 1μM for 3 
hours and beta estradiol (Sigma) at 10 nM for 1 hour in phenol red free DMEM/F-
12 supplemented with 10% charcoal dextran treated, heat inactivated FBS 
(Atlanta Biologicals) and human insulin, human transferrin and sodium selenite 
(ITS) (Sigma). Treatments with Triptolide (TRP) (Sigma) and Flavopiridol (FP) 
(Sigma) were carried out after the above-described activations. TRP was used at 
a final concentration of 2.5 μM and FP at 5 μM. 
2.2 RNA Extraction 
 Total RNA was extracted from cells using the Qiashredder and RNeasy kit 
(Qiagen). 500ng of RNA was run on a 1% agarose gel with TAE buffer to check 
the integrity of each sample. 1 μg of total RNA was used in reverse 
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transcription with SSRTIII reverse transcriptase (Invitrogen) with random 
hexamer (Invitrogen) priming. The cDNA was then subjected to quantitativereal 
time PCR using gene specific primers and all samples were normalized against 
GAPDH gene. All data points are averages of three biological replicates with 
standard error of the mean. Once validated, the RNA was checked again for 
integrity and sent for RNA sequencing. 
2.3 Permanganate Footprinting 
 Treatment of cells with potassium permanganate and all subsequent 
reactions were performed as described previously for mammalian cells 
(Samarakkody et al. 2015). All treatments with potassium permanganate were 
done on freshly treated cells after washing with PBS buffer. Cells pellets were 
resuspended in 50 μL PBS buffer, and then treated with 300 μL of ice cold 20 
mM KMnO4 for 1 minute and the reaction was immediately stopped with 400 μL 
of stop solution (20 μL of 5M NaCl, 100 μL of 1M Tris-HCl pH 7.4, 300 μL of β-
mercaptoethanol (Sigma), 400 μL of 500 mM EDTA and 500 μL of 10% SDS). 
The cell lysate was treated with 3 μL of RNA cocktail (Ambion) at 37οC for 30 
minutes and Fungal Proteinase K (Life Technologies) overnight at 56οC. 6 μg of 
purified DNA was treated with piperidine (Sigma) in 100 μL and extracted twice 
with chloroform. 250 ng of piperidine treated DNA was used in primer extension 
with a gene specific primer A using Phusion high fidelity polymerase (Thermo 
Scientific) and Hight Fidelity (HF) buffer. Subsequently the single stranded DNA 
were ligated to a double stranded linker A’:B overnight at 16οC in the presence of 
T4 DNA Ligase (ThermoScientific). The DNA was amplified after ethanol 
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precipitation with gene specific primer B and universal linker A primer for 22 
cycles and an additional two cycles of PCR with 32P radioactively labeled gene 
specific primer C. The reaction was phenol-chloroform extracted, ethanol 
precipitated and run on a denaturing 7% urea TBE gel.   
2.4 Immunoblot Assay 
 Cellular extracts were prepared in lysis buffer (8M urea and 1M Tris HCl 
pH 8.0) with protease inhibitor cocktail (Sigma). Total cell extracts were run on a 
10% SDS-PAGE resolving gel alongside full-range rainbow marker (GE 
Healthcare Life Sciences) and transferred onto a PVDF membrane using 
standard technique of wet transfer under chilled conditions. The blot was then 
blocked in 5% milk in TBS buffer with 0.1% tween for one hour and 
immunoblotted against anti-RNA Polymerase Ser-2 (Millipore), anti-Actin (Life 
Technologies), anti-cMyc antibody (Abcam ab32072) overnight at 4 οC. The blots 
were then incubated for one hour with the horse radish peroxidase (HRP) 
conjugated secondary antibody (GE Healthcare Life Sciences) at a dilution of 
1:10,000. The blot was then treated with Luminata Forte Western HRP substrate 
(EMD Millipore) for 5 minutes before imaging on the Odyssey imager.  
2.5 Depletion using siRNA 
 siRNA sequences for XRN-2 and NELF were selected through the 
Silencer Select tool by ThermoFisher Scientific and those for CDK9 was used as 
previously published and CDK-9 antibody (A303-493A-M) from Bethyl 
Laboratories  (Yu et al. 2015). The siRNA was diluted in a 1:1 mix of 
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Lipofectamine-3000 and Opti-MEM to a final concentration of 10 nM. The cells 
were plated at a density of 60% and grown for 72 hours.  
2.6 In vitro Synthesis of Capped RNA 
 DNA sequences were designed based on the mouse genome with 30-75 
nucleotides in length, having a G nucleotide as the start with the T7 promoter 
sequences at the 5’ end. The designed template sequence was to ensure that it 
did not match to the human genome using the BLAT tool on the UCSC genome 
browser (Kent 2002)The whole DNA sequence together with the T7 promoter 
sequence was considered as the forward sequence which would serve as the 
sense strand during subsequent in vitro transcription. The forward and the 
complimentary reverse strands were mixed at a final concentration of 10 μM in 
TE buffer in a total of 100 μL and annealed with a program ramping down from 
95οC to 4οC. The reaction was then precipitated with 3 volumes of ethanol and 6 
μL of 5M NaCl. Using 1 μg of the annealed DNA template the in vitro 
transcription reaction was set up using the T7 Megascript kit (Ambion) as 
recommended and incubated overnight at 37οC. The reaction was then treated 
with 1 μL of TURBO DNase as recommended and the reaction was stopped by 
adding the ammonium acetate solution as recommended. Then the RNA was 
extracted using acid-phenol/chloroform and then again with chloroform before 
precipitating with 3 times the volumes of ethanol. Then the RNA was then 
precipitated at -80οC for at least 30 minutes and pelleted using a cold centrifuge 
at maximum speed for 20 minutes. The RNA pellet was washed with 80% 
ethanol, air dried to remove residual ethanol, and resuspended in 20 μL of water. 
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The RNA was then mixed with an equal volume of 2X gel loading dye provided 
with the Megascript kit and heated at 65οC for 5 minutes. The RNA was then 
loaded on a 15% Urea-TBE gel that was pre-run for 20 minutes alongside the 
single stranded RNA marker (NEB) and run at 200 V until the dye front reaches 
the bottom of the gel. The band that corresponds to RNA of the expected length 
was extracted from the gel and extracted using the crush and soak method, 
where the gel pieces were placed in a gel breaker tube (Agilent) that’s placed in 
a 1.5 mL Eppendorf tube and spun at 12000g for 5 minutes. The crushed gel was 
then shaken at room temperature in 400 μL of 300 mM NaCl for 4 hours. The gel 
homogenate was then spun through a 0.22 μM filter column (Agilent) for 
5 minutes at 2000g. The flow though was then precipitated with 3 volumes of 
ethanol and incubated in -80οC for 30 minutes before spinning at maximum 
speed in a cold centrifuge to pellet the RNA. The RNA was washed in 80% 
ethanol and resuspended in 20 μL of nuclease free water. A microliter each of 
this RNA was quantified using both the Nanodrop and the Bioanalyzer 
instruments.  
 A 7-methylaguanylate capped structure was added to the 5’ end of these 
RNA using the Vaccinia capping system (NEB). The RNA was first heated at 
65οC for 5 minutes and immediately placed on ice. Then to 15 μL of the gel 
extracted RNA was combined with 2 μL of 10X capping buffer, 1 μL 10mM GTP, 
1 μL of 2 mM SAM after dilution and 1 μL of Vaccinia capping enzyme was 
added and incubated at 37οC for one hour. The capped RNA was then extracted 
using acid-phenol/chloroform as described above. 
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 The efficiency of capping of each capped RNA was then checked using 
the following four reactions where 200 ng of RNA was used in each reaction: 
Reaction A: Treatment with 5’ phosphate dependent RNA polyphosphatase 
(Epicentre)  
Reaction B: Treatment with 5’ phosphate dependent RNA polyphosphatase 
(Epicentre) followed by Terminator exonuclease (Epicentre) 
Reaction C: Treatment with RNA 5’ Pyrophosphohydrolase (NEB)with followed 
by Terminator exonuclease (Epicentre) 
Reaction D: Treatment with RNA 5’ Pyrophosphohydrolase (NEB) alone 
 These four reactions were performed for each in vitro RNA and then was 
mixed with equal volume of gel loading buffer II (Ambion). The RNA was then 
loaded directly on a 15% Urea-TBE gel that was pre-run for 20 minutes and the 
gel was run at 200 V. A successfully capped RNA will be retained after all 
reactions except for reaction D, and if RNA is not reliably capped, there will be a 
decrease in reactions B and D. The capped RNA was diluted such that when 
added to the nuclei or chromatin in Trizol, the in vitro-synthesized RNA was in 
the range of 10-50 molecules per cell.  
2.7 Short Capped RNA Library Preparation 
 MCF-7 cells from different treatment points were used in the library 
preparation using approximately 108 cells in two 15 cm dishes at about 90% 
confluency. Cells were harvested and washed with 1X PBS buffer prior to nuclei 
isolation. 
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2.7.1 Nuclei Isolation 
 Cells were directly resuspended in 2 mLs of the cell lysis buffer (Williams 
et al. 2015) containing 10 mM Tris-HCl (pH 8.0), 200 mM Sucrose, 3 mM CaCl2, 
2 mM MgCl2, 0.1% Triton X-100, SUPERase In RNase Inhibitor (Ambion), and 
Proteinase Inhibitor Cocktail (Sigma-Aldrich). The cell lysate was incubated on 
ice for 10 minutes and further lysed in a douncer with 20 strokes. The lysate was 
centrifuged at 1000 g in a cold centrifuge for 10 minutes to precipitate the nuclei 
and the nuclei was washed to remove traces of cytoplasm. 5% of the cell 
fractions were used in immunoblotting and qRT PCR analyses to confirm the 
reliability of fractionation.  
2.7.2 Chromatin Isolation 
 Cells from two 15 cm dishes at about 80% confluency were scrapped in 
media and washed twice in cold PBS. The cells were resuspended in 10 mL of 
swelling buffer (10 mM TRIS-Cl pH 7.5, 2 mM MgCl2 and 3 mM CaCl2) and 
allowed to swell on ice for 5 minutes. Centrifuge at 2000g for 10 minutes and 
then remove the supernatant. Resuspend cell in 1 mL of Lysis buffer (10 mM 
TRIS-Cl pH 7.5, 2 mM MgCl2, 3 mM CaCl2, 0.5% Igepal, 10% Glycerol, 2 units of 
Superase In) and gently pipette 20 times to lyse the cells. The lysate was brought 
up to 10 mL and the nuclei pelleted by centrifuging at 2000 g for 10 minutes. The 
isolated nuclei were resuspended in 125 μL of NUN1 buffer (20 mM TrisHCl pH 
8.0, 75 mM NaCl, 0.5 mM EDTA, 50% Glycerol and Proteinase Inhibitor 100x 
(Sigma)), followed by 1.2 mL of NUN2 buffer (20 mM HEPES-KOH pH 7.6, 7.5 
mM MgCl2, 0.2 mM EDTA, 300 mM NaCl, 1M Urea, 1% NP40 and Proteinase 
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Inhibitor 100x (Sigma)). The nuclei were incubated for 15 minutes on ice for 
complete lysis while vortexing for 5 seconds every 4 minutes at maximum speed. 
The chromatin was pelleted by centrifugation at 13,000g for 10 minutes in a cold 
centrifuge.  
2.7.3 Isolation of short RNA from Chromatin  
and Nuclei Fractions 
 
 Nuclei or chromatin pellets were resuspended in Trizol to extract RNA with 
subsequent chloroform extraction and ethanol precipitation. The RNA was 
resuspended in nuclease free water, treated with DNase I (NEB) and incubated 
at 37οC for 30 minutes. Then the reaction mixture was mixed with equal volume 
of 2X gel loading buffer (Invitrogen) and heating at 65οC for 5 minutes. The 
samples were loaded 20 μ g RNA per well on a 15% urea-TBE gel  
10-well 1 mm thick gel (Invitrogen), alongside short range single stranded RNA 
ladder (NEB), after pre-running for 20 minutes at 200 V. A section with short 
RNAs between 20 to 80 nucleotides in length was cut from the gel and the RNA 
was extracted using crush and soak method (Nechaev et al. 2010). The gel 
pieces were crushed by placing them in gel breaker tubes (Agilent) inserted in a 
1.5 mL Eppendorf tube and spinning in a bench top centrifuge at 12000g for 
5 minutes. Then 400 μL of 300 mM NaCl was added to the crushed gel to extract 
the RNA by shaking for 4 hours at room temperature. The gel slurry was then 
transferred to 0.22 μ M spin filter tubes (Agilent) and spun at 2000 g for 5 
minutes. The RNA was pelleted with 3 volumes of ethanol and 1 μ L of GlycoBlue 
co-precipitant (Ambion) by incubating in -80 οC for at least 30 minutes before 
spinning down at maximum speed in a chilled centrifuge for 20 minutes. The 
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precipitated RNA washed with 80% ethanol and air dried prior to resuspending in 
20 μ L of nuclease free water. One microliter each was used in quantification by 
nanodrop and bioanalyzer 2100 (Agilent). 
2.7.4 Library Preparation with small capped RNA 
 Approximately 700 ng of nuclear RNA and 300 ng of Chromatin bound 
RNA was used in the library preparation protocol. 15 μL of size selected small 
RNA was first denatured at 65οC and treated with 1 μL of T4 Polynecleotide 
Kinase- 3’ phosphate minus (NEB) in the presence of 2 μ L of 10X T4 
Polynucleotide Kinase buffer and 1 μL of Murine RNase Inhibitor (NEB) and 1 μL 
of 10 mM ATP and incubated at 37οC for 30 minutes. This reaction would allow 
phosphorylation of any degradation products at their 5’ end of the RNA. The 
reaction was made up to 100 μL with nuclease free water (Ambion) and extracted 
with 50 μL of acid-phenol/chloroform pH 4.5 with isoamyl alcohol, then with 50 μL 
of chloroform and precipitated with 3 volumes of ethanol and 6 μL of 5M NaCl 
and precipitated as described above. The RNA was resuspended in 17 μL of 
nuclease free water and denatured at 65οC and immediately placed on ice. 2 μL 
of 10X reaction buffer for 5’ RNA phosphate dependent polyphosphatase and 1 
μL of 5’ RNA phosphate dependent polyphosphatase (Epicentre) was added to 
the RNA and incubated at 37οC for 30 minutes. The reaction was precipitated as 
described above and resuspended in 17 μ L of nuclease free water and 
denatured at 65οC as described above. Then the RNA was treated with 1 μL of 
Terminator Exonuclease (Epicentre) in the presence of 2 μ L of 10X reaction 
buffer and incubated at 30οC for an hour and there after the reaction was 
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precipitated as described above. The terminator exonuclease degrades RNA with 
a 5’ monophosphate in a 5’ to 3’ direction.  
 Before the next step of ligating the 3’ adapter to the RNA, the adapter 
sequence was preadenylated using the 5’ DNA adenylation kit (NEB) as 
described in the NEB protocol. After the reaction was extracted with 
phenol/chloroform with isoamyl alcohol (pH 7.5) (Sigma) and with Chloroform 
(Sigma) and precipitated in the presence of 6 μL 5M NaCl with 3 volumes of 
ethanol. The reaction was run through Bio-Spin 6 column (Biorad) as per 
manufacturer’s instructions to remove remaining ATP.  
 After the reaction with Terminator Exonuclease the RNA was resuspended 
in 7 μL of nuclease free water and mixed 1 μL of preadenylated 3’ RNA adapter 
and incubated at 70οC for 2 minutes and placed on ice immediately. To the mix, 
2 μL of T4 RNA Ligase buffer and 1 μL of T4 RNA Ligase 2, truncated K225Q 
(NEB) and incubated at 28οC for 1 hour and 20οC for two hours. Then 10 μl of 2X 
Gel loading buffer II was added, heated at 65οC for 5 minutes and loaded on a 
15% Urea Polyacrylamide gel after pre-running for 20 minutes at 200 V, 
alongside low range single stranded RNA ladder (NEB). Gel selection 
corresponding to the RNA ligated to the 3’ adapter, 100-40 nucleotides was 
excised and extracted from the gel using the cut and soak method as previously 
described. The adapter ligated RNA was then resuspended in 18 μL of nuclease 
free water and incubated at 37οC for 30 minutes with 1 μL of Murine RNase 
Inhibitor and 1 μL of Shrimp alkaline phosphatase. The RNA was extracted with 
acidic phenol/chloroform and ethanol precipitated as previously described. The 
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RNA was then resuspended in 16 μL of nuclease free water and incubated at 
37οC for 2 hours with 2 μL of 10X NEB Thermopol Buffer and 2 μL of RNA 5’ 
Pyrophosphohydrolase and extracted with phenol/Chloroform followed by ethanol 
precipitation. RNA was then resuspended in 6 μL of nuclease free water and 
denatured at 70οC for 2 minutes. The second ligation reaction for the RNA was 
set up with 1 μL 10mM ATP, 1 μL of RNA 5’ adapter, 1 μL of Murine RNase 
Inhibitor and 1 μL T4 RNA Ligase 1 (NEB). The ligation reaction was incubated at 
28οC for an hour and 20οC for 2 hours. After the ligation of the 5’ adapter the 
reaction was directly used in reverse transcription. 1 μl of 50 mM TruRT primer, 
5X First strand synthesis buffer (Invitrogen), 0.1 mM DTT (Invitrogen), 12.5 mM 
dNTPs and SSRTII (Invitrogen) was added directly to the reaction tube after 
ligation and incubated at 50οC for one hour. After reverse transcription, 10 μL of 
5X Phusion buffer, 2 μL of TruRTP primer and 2 μL of TruTPI indexed primer 
was used in PCR with high fidelity Phusion polymerase (ThermoFisher Scientific) 
The thermal program used was as follows; initial denaturing step of 94οC for 
30 seconds, 16 cycles of 94οC for 15 seconds, 62οC for 30 seconds and 70οC for 
15 seconds and a final extension at 70οC for 5 minutes. 
 Each library was mixed with 10 μL of 6X purple gel loading dye (NEB) 
after the PCR amplification and directly loaded in two wells of a 6% non-
denaturing polyacrylamide TBE 1mm thick gel (Invitrogen), alongside 25 base 
pair DNA ladder (NEB) and run at 100 V until the dye front reached the bottom of 
the gel. The library between 200-150 base pairs was cut from the gel and 
extracted with 400 μL of 300 mM NaCl using the crush and soak method.  
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 The final library was resuspended in 20 μL of nuclease free water and a 
microliter was used in both Nanodrop and Bioanalyzer quantification. Prior to 
sequencing the inserts of libraries were validated by ligating about 30 ng of the 
gel selected purified library to pBlueScript vector, that was dephosphorylated, 
using T4 DNA ligase (ThermoFisher) followed by transforming the ligated DNA 
into DH5-α Escherichia coli competent cells. Plasmids from 12-15 individual 
clones with inserts were sequenced and the inserts were confirmed using the 
BLAT tool on the UCSC genome browser (Kent 2002). The scRNA libraries were 
sequenced on the Illumina MiSeq sequencer at the UND Epigenetics and 
Bioinformatics Core using the RNA LT option in 50 base pair reads in a paired 
end mode, using V3 150 cycle MiSeq kit.  
2.8 Data Analysis 
2.8.1 RNA-seq Analysis 
 
 The fastq files from the RNA-seq data were aligned to the human genome 
(hg19) using topthat:  
tophat2 -p 5 -o <folder_name> --transcriptome-index=transcriptome_data/ -G 
genes.gtf genome sample.fastq.gz 2> ./ sample.stderr 
 The output sam file was converted to bam format, sorted, indexed and 
used in R to generate a list of genes with differential expression using custom 
scripts: 
 samtools sort sample.bam -o sample.BAM 
 samtools index sample.BAM -o sample.bai 
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The differential expression was determined at p value of 0.01 using 2 replicates 
for each time point of heat shock. 
2.8.2 scRNA-seq Analysis 
 The paired end mode generates 2 fastq files containing the sequenced 
reads; read 1 (R1) and read 2 (R2). Due to the RNA insert is fairly short, during 
sequencing the adapters also get sequenced. Hence, the sequences were first 
trimmed for the adapter sequences using cutadapt (Martin 2011). The adapter 
trimmed files were then aligned with the hg19 human reference genome from 
UCSC genome browser using the version 1.1.1 of bowtie (Langmead et al. 
2009). The alignment was done with 2 allowable mismatches and the reads that 
had non-unique alignments to the genome ware disregarded (Scheidegger et al. 
2015). The unaligned sequences were output into a separate fastq file and 
generated a bowtie file using the following command:  
 bowtie -p 6 -q -m 1 -n 2 --un sample_un.fastq 
/local_storage/annotation_db/Homo_sapiens/UCSC/hg19/Sequence/Bowti
eIndex/genome sample sample.bowtie 
 From the aligned file of bowtie, an unbinned bedgraph file was generated 
for visualization on the UCSC genome browser using the perl script 
bowtie2bedgraph script as published (Scheidegger et al. 2015).  
 bowtie2bedgraph.pl sample sample /local_storage/annotation_db/Homo_ 
sapiens/UCSC/hg19/hg19_chrominfo.txt 
R1 reported the 5’ end of the RNA, corresponding to the transcription start site, 
and the R2 the 3’ end, equivalent to the pause site for short RNAs coming from 
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paused Pol II. For each sample of the scRNA fastq file, four bedgraph files were 
generated separating the forward and reverse strand for each R1 and R2 in the 
paired end format; R1_forward, R1_reverse, R2_forward and R2_reverse. These 
bedgraph files were normalized using the counts of in vitro synthesized spike-in 
RNAs in each sample, assuming that RNA losses of those RNAs through the 
processes of RNA extraction and library preparation across samples are the 
same. Spike-in RNA counts for each spike-in sequence was counted in each 
fastq file using the following command where <sequence> would be the actual 
sequence of the spike-in RNA:  
 grep -A 2 -B 1 <sequence> sample.fastq | sed '/--/d' > output.fastq.gz 
 zcat output.fastq.gz | echo $((`wc -l`/4)) 
The normalization for bedgraphs were performed by normalizing the counts for 
all the spike-ins across samples. 
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CHAPTER III 
RNA POLYMERASE II PAUSING IS RETAINED  
DURING GENE ACTIVATION 
 
3.1 Pol II Pausing at Basal Levels is Positively Correlated 
with Levels of Transcription 
 
 The levels of Pol II pausing on different genes vary greatly across the 
genome as shown by multiple genome-wide studies in both Drosophila and 
mammalian systems (Zeitlinger et al. 2007; Muse et al. 2007). This prompts the 
question whether Pol II pauses at basal conditions to allow rapid activation in 
response to a stimulus. Recent evidence shows that genes that lack Pol II 
pausing at basal levels are activated just as fast as genes that has significant 
levels of Pol II pausing prior to induction (Lin et al. 2011; Gilchrist et al. 2012; 
Chen et al. 2013). Moreover, genome-wide analysis of mammalian transcription 
rates revealed that induction of paused genes in response to TNF-α in fact shows 
a slight delay in activation (Danko et al. 2013). In Drosophila embryos, Pol II 
pausing is present on many genes that are not subsequently activated during 
development (Levine 2011). This evidence suggests that rapid activation is 
unlikely to be the main reason for Pol II pausing. Another hypothesis was that Pol 
II pausing may result in more synchronous activation of genes following a 
stimulus (Boettiger & Levine 2009) and perhaps, at basal conditions as well. To 
determine if pausing is coupled with productive transcription, we compared 
expression levels of EMT related genes to levels of Pol II pausing in a panel of
 39 
human cancer lines, selected based on their varying expression of SNAI1 at 
steady state conditions; MCF-7 (human breast epithelial cancer cell line), A375 
(human epithelial melanoma cell line), MDA-MB-231 (human breast epithelial 
adenocarcinoma cell line), T47D (human mammary ductal carcinoma cell line) 
and A549 (human lung carcinoma cell line). We used potassium permanganate 
footprinting to detect Pol II pausing on promoters of three genes, Snail (SNAI1), 
Slug (SNAI2) and E-Cadherin (CDH1) in comparison to their mRNA expression 
levels. Potassium permanganate footprinting is based on a previously published 
protocol (Gilmour & Fan 2009) that we further optimized for the analysis of 
mammalian cells. Noteworthy are several features of pausing: first, 
permanganate reactivity for each gene is present at the same location across cell 
lines (Figure 3), suggesting that the mechanisms that regulate Pol II pausing in 
these cell lines are similar. Second, Pol II pausing signal is higher with higher 
levels of steady state gene expression, thus highlighting a fundamental 
relationship between pausing and transcription in the absence of activation. The 
differences in levels of pausing and transcription across cell lines are, perhaps, a 
result of differences in chromatin architecture, which determines how accessible 
the promoter regions are.  
3.2 Pol II Pausing levels are increased with activation of the SNAI1 gene 
 SNAI1 gene is one of the highly paused genes in MCF-7 but is expressed 
at low levels in MCF-7 cells (Dhasarathy et al. 2007), indicating that perhaps 
SNAI1 is poised for activation. Using several activating signals, we followed 
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Figure 3.  Levels of Pol II pausing is associated with basal levels of 
transcription independent of activation. (A) Permanganate footprints 
for SNAI1, CDH1 and SLUG genes across different human breast 
cancer cell lines demonstrate that high Pol II pausing signal 
correlates with high levels of basal expression. (B) mRNA levels 
analyzed in the same cell lines as shown in A. All values derive 
from three independent experiments, and are plotted based on Ct 
difference between the indicated gene and GAPDH.  
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changes in Pol II pausing status on SNAI1 upon activation. We treated MCF-7 
cells with 17β-estradiol (E2), a natural ligand of estrogen receptor alpha that was 
previously shown to cause transient upregulation of SNAI1 in MCF-7 cells (Hah 
et al. 2011), and followed a time course of transcriptional response (Figure 4A). 
While MCF-7 cells showed an increase in SNAI1 RNA levels relative to GAPDH 
control gene, we did not observe a change in the location of pausing with 
activation, consistent with what was previously observed (Hah et al. 2011). 
Further, the Pol II pausing signal did not change and, specifically, did not 
decrease during the time course of gene activation as would be expected for 
pause release (Figure 4A), consistent with previous data using Global Run-on 
sequencing (Gro-seq) (Hah et al. 2011). However, the effect of E2 on MCF-7 
cells is short-lived as demonstrated by another group (Danko et al. 2013). We 
tested another system, a well-studied system of EMT that has been previously 
shown to upregulate SNAI1 expression. We treated NMuMg,(Namru murine 
mammary gland epithelial cells) with transforming growth factor beta (TGF-β). 
SNAI1, a gene that is not paused in mouse cell lines gains Pol II pausing upon 
treatment with TGF-β (Figure 4B). We then investigated the effects of the 
compound Trichostatin A (TSA), a histone deacetylase inhibitor, that activates 
SNAI1. Similar to activation with E2, activation of SNA1 gene transcription is 
followed by an increase in Pol II pausing signal, which with TSA is the highest at 
3 hours (Figure 4C). This response is not unique to MCF-7 cells, as SNAI1 
mRNA also gets upregulated in response to TSA treatment of MCF-10 A (non-
tumorigenic human breast epithelial cell line).  
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Figure 4.  Pol II pausing signal is increased with gene activation. 
(A). Permanganate footprint on SNAI1 gene with E2 treatment of 
MCF-7 cells and mRNA fold change as detected by RT-PCR 
normalized to GAPDH. RT-PCR represents an average of three 
independent replicates. (B). Mouse NMuMG cells treated with TGF-
β RT-PCR and permanganate footprinting represents an average of 
three independent replicates. (C). MCF-7 cells treated with TSA. 
RT-PCR represents an average of four independent replicates. The 
regions of permanganate reactivity emerging during activation of 
mouse Snai1 and human SNAI2 genes are shown alongside the 
gel as a gray rectangle. 
 
3.3 Pol II Pausing during Activation of SNAI1 Gene 
 The increase in Pol II pausing during gene activation is indicative of an 
increase in Pol II occupancy at the promoter region. The increase in Pol II 
pausing can be a result of increase in recruitment of Pol lI in response to gene 
activation, or due to a decrease in residence time leading to high turnover of Pol 
II at the paused site. At a given time, only a single molecule of Pol II can occupy 
the paused site. Therefore, the increase in pausing  during gene activation is due 
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to more cells in the population gaining Pol II pausing on the SNAI1 gene due to 
increased recruitment with activation. To investigate what fraction of cells, and 
gene copies, in a population was occupied by paused Pol II on SNAI1 gene, we 
used artificial templates based on the human SNAI1 gene sequence and 
containing an artificial transcription bubble. By measuring permanganate 
reactivity on artificial templates containing the known proportion of bubble, we 
determined that permanganate footprinting faithfully reports the relative propotion 
of bubbles on a gene. Based on 3 biological replicates we determined that the 
Pol II occupancy increases by 2-fold during TSA activation using 3 independent 
replicates. Given that TSA activation of MCF-7 cells leads to about 2 fold 
increase in permanganate signal on SNAI1 gene, our data allowed us to 
postulate a 2-fold increase in the fractional occupancy of the SNAI1 gene in vivo. 
This means that the highly paused SNAI1 gene was not fully occupied prior to 
activation and the occupancy at basal levels was less than 50%.  
 Next we sought to find if the activation of SNAI1 gene involves a change in 
residence time of paused Pol II. To determine changes in residence time of Pol 
II, we used TRP which specifically inhibits TFIIH (Titov et al. 2011). TRP inhibits 
recruitment of Pol II and thereby allows us to follow the Pol II complexes that are 
already paused (Henriques & Adelman 2013; Jonkers et al. 2014). We observed 
that the TSA activation of SNAI1 gene (last four lanes of Figure 5A) does not 
speed up the turnover of pausing (first four lanes of Figure 5A). We demonstrate 
that the activation of SNAI1 by TSA does not involve changes in Pol II dynamics 
and that the activation takes place through increase in Pol II recruitment and 
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Figure 5.  The SNAI1 gene is activated through Pol II recruitment without 
changes in Pol II pausing duration. A. Pause signal decays in the 
presence of Triptolide (TRP). Quantitation of permanganate 
footprints (below), from three independent experiments. B. 
Permanganate footprinting of artificial bubble templates was done 
with SNAI1 +100 primer set. A+G ladder and reactivity of MCF-7 
cells, treated and untreated with TSA, is shown for comparison. 
Permanganate shows linear response to the proportion of 
transcriptional bubble. Quantitation of the experiment as in A. The 
values were obtained from three experiments and represent the 
area under the curve in the indicted part of the footprint.  
 
transcription initiation events. This experiment demonstrates, for the first time, 
that a gene can be transcriptionally activated without changes in pause duration. 
Other genes, notably, HSPA1B heat shock protein 70 gene, have been shown to 
change pause duration during activation in both Drosophila and mammalian 
systems (Lis, 1998, Mahat et. al 2016). Our results point to a previously 
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unsuspected role of pausing during transcriptional responses. To investigate if 
the mechanisms involved in activation of SNAI1 gene with TSA are distinct 
across cell lines, we followed activation in A375 cells, a human melanoma cell 
line. We note that both SNAI1 and SNAI2 genes get upregulated upon treatment 
with TSA (Figure 6A) in A375 cells just as they do in MCF-7 cells. Upon following 
the dynamics of the paused Pol II complex we observe that TSA activation of 
SNAI1 gene in A375 cells does not involve changes in pause duration. 
 
 
Figure 6.  TSA activation of SNAI1 gene occurs through does not involve 
change in Pol II pausing duration. A. mRNA fold change upon 
treatment with TSA in A375 cells. B. Footprint for SNAI1 gene upon 
TSA activation and C. the quantification plot of the relative footprint 
in the presence of TRP.
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3.4 Context-Dependent Release of Pol II Pausing during Gene Activation 
 Transcription initiation and Pol II pausing are two key processes that 
regulate early stages of transcription (Adelman & Lis 2012). Different signaling 
pathways have been in principle shown to activate transcription through either 
increase in initiation or release of pausing (Danko et al. 2013). However, this 
study employed activation in two different cell lines; MCF-7 cells stimulated with 
E2 and AC16 cardiomyocyte cells treated with TNF-α. Whether the same gene 
could be activated through two distinct mechanisms of pause release, and 
increase in Pol II recruitment in the same cell line was unknown. To follow 
activation of the same gene by different stimuli, we studied the heat shock 
pathway in MCF-7 cells, which upregulated the heat shock protein 70 (HSPA1B) 
gene. As previously observed in Drosophila (Gilmour & Lis 1986) and mouse 
systems (Mahat et al. 2016), we observed an increase in mRNA levels of 
HSPA1B in MCF-7 cells (Figure 7A). Previous reports have demonstrated that 
Pol II pausing gets completely obliterated in non-heat shock related genes in 
Drosophila (Yao et al. 2006). In contrast, the SNAI1 gene remains paused during 
heat shock activation of MCF-7 cells. These results suggest that heat shock 
activation in mammalian cells is different than in Drosophila. We note that the 
activation of HSPA1B by TSA depends on an increase in Pol II recruitment and 
that activation by heat shock proceeds through pause release, demonstrating for 
the first time that the same gene can be activated by distinct mechanisms 
depending upon the stimuli (Figure 7B). 
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Figure 7.  Pol II pausing is retained on HSPA1B gene during activation under 
the conditions of pausing release. (A) Permanganate footprinting 
for the time course of heat shock, shown for HSPA1B gene. The 
region of pausing is highlighted in gray. (B) Activation of HSPA1B 
gene with TSA (3 h) and heat shock (30 min), shown alongside 
naked DNA and the A/G ladder. 
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CHAPTER IV 
PAUSING DYNAMICS DURING TRANSCRIPTIONAL RESPONSES REVEAL 
REDIRECTION OF PAUSED RNA POLYEMRASE II 
 
4.1 Activation with TSA Results in Robust Transcriptional  
Response that is Common Across Cell Lines 
 
 To monitor changes in dynamics of Pol II pausing in response to stimuli, 
we tested global transcriptional responses to two distinct stimuli. Firstly, we 
chose TSA which has been previously shown to induce stress pathways. Gene 
activation with TSA, unlike that with heat shock, is not known to involve a specific 
transcription factor. To determine which genes were activated in response to two 
distinct stimuli TSA and heat shock, we performed mRNA-sequencing (RNA-seq) 
of MCF-7 cells following exposure to these stimuli. Among the time points that 
were published for TSA, we chose the 3 hour time point, as it gave the highest 
fold increase of SNAI1 mRNA. Using a fold change cutoff of 1.3 and stringent 
criteria of adjusted p-value of less than 0.5, we identified genes that are 
differentially expressed upon TSA treatment. 
 Activation with TSA leads to a robust change in transcription. A higher 
number of genes are differentially expressed during TSA treatment of MCF-7 
than in A375 cells (Figure 8). To investigate if transcriptional changes in 
response to stress are specific to the cell type, we performed RNA-seq analysis 
on A375 cells upon treatment with TSA. We observe that MCF-7 cells 
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Figure 8.  A large number of genes undergo changes in transcriptional levels 
during TSA treatment. Plot showing mean expression vs log fold 
change in A375 (A), and MCF-7 cells (B). in response to TSA 
treatment.
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are more responsive to TSA in terms of the number of cells that appear to be 
differentially regulated upon TSA treatment relative to the control (Figure 9A and 
9B). We observe that similar groups of genes are activated with TSA in both 
A375 and MCF-7 cells as per Gene Ontology (GO) analysis (Figure 9C and 9D). 
Thus, TSA treatment results in robust transcriptional responses despite the 
variation across the two cell lines. 
4.2 Heat Shock of MCF-7 Cells Differentially Regulates  
Metabolism Related Genes 
 
 We next chose the heat shock response (HSR), a stress response 
pathway active in cancer cells (Mendillo et al. 2012), which is well studied with 
regards to Pol II pausing. HSR involves the recruitment of transcription factors 
called heat shock factors (HSF)s, especially HSF-1, to the promoter regions of 
some genes. During HSR not all genes are upregulated in a HSF-1 dependent 
manner, indicating distinct mechanisms of gene activation with the same stimuli 
(Mahat et al., 2016). We used 42οC for heat shock with 30, 60 and 120 minutes 
as published for the SNAI1 and HSPA1B genes (Samarakkody et al., 2015).  
 We first sought to identify early response genes of the HSR and genes 
that are upregulated later during heat shock. We observed a higher number of 
genes that are upregulated than downregulated during HSR. In addition, more 
genes are upregulated with longer duration of heat shock in MCF-7 cells. We 
note that RNA sequencing is biased against downregulated genes relative to 
nascent RNA analysis methods such as PRO-seq. PRO-seq is thus better suited 
for detecting downregulated genes (Mahat et al. 2016), and can be used in future 
work.  
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Figure 9.  Metabolic processes are largely affected during TSA treatment of 
both MCF-7 and A375 cells.  Venn diagrams showing the number 
of genes in MCF-7 (blue circle) and A375 (green circle) cells that 
are upregulated (A) and downregulated (B) during TSA treatment. 
Pie charts generated using the Panther program showing 
categories of genes that are upregulated (C) and downregulated 
(D) in both MCF-7 and A375 cells. 
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 The activation of genes following the HSR that we observe here is 
consistent with what has been previously reported. The three genes upregulated 
at 30 minutes of heat shock (Figure 7B), HSPA1B, HSPA1A and DNAJB1 (a heat 
shock protein 40), are genes in the HSR pathway (Table 1 and Figure 10A).  
 
Table 1. The number of genes that are differentially expressed during heat 
shock response. The number of genes listed meet the criteria of adjusted  
p-value of 0.5 and have a log fold change of greater than 1.3. Each data point 
is representative of two independent replicates. 
 Upregulated genes Downregulated genes 
Heat shock 30 minutes  3  0 
Heat shock 60 minutes  108  2 
Heat shock 120 minutes  213  5 
 
 When cells were heat shocked for a longer period of 60 minutes, 
108 genes, including HSPA1B, HSPA1A and DNAJB1, were upregulated. While 
there were a larger number of genes that were significantly upregulated, 2 genes 
(red dots in Figure 10B) appeared to downregulated. Among the upregulated 
genes most genes are related to metabolism and other cellular processes (Figure 
10C) as expected. At a longer time point with heat shock, more genes get 
upregulated (Figure 10D). We also note that some genes get transiently 
upregulated during heat shock. We note that 17 genes appear as differentially 
expressed only at 60 minutes (Table 2) and 125 genes only at 120 minutes. Well-
known early response genes such as JUN and FOS are two examples of genes 
that are significantly upregulated at 60 minutes but not at 120 minutes of heat 
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Figure 10.  Genes involved in metabolism are upregulated during heat shock 
response. Plot showing the average expression and fold change at 
(A) 30 minutes, (B) 60 minutes and (D) 120 minutes Gene ontology 
analysis of genes that are identified as differentially expressed 
upon heat shock at (C) 60 minutes and (D) 120 minutes. 
 
shock. These data provide evidence that some genes are activated early during 
the stress response, and some genes are activated in a transient manner.  
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Table 2. List of genes that are differentially 
expressed only at 60 minutes. The list of 
genes is sorted by the fold change and the  
p value is adjusted to disregard genes that 
have very low level of expression at basal 
stage. 
Gene Fold 
Change 
p value 
JUN 2.79 6.63E-06 
PPP1R3C 2.78 1.01E-05 
AP4B1-AS1 2.71 1.13E-05 
RAET1K 2.41 0.000283347 
PPP1R15A 2.38 0.000449711 
ZC3H12A 2.38 0.000324101 
FAM43A 2.28 0.000459722 
FOS 2.26 0.00101959 
ARC 2.23 0.001200184 
DNAJB5 2.20 0.001553058 
PSMD6-AS2 2.10 0.003984572 
CIART 2.09 0.008118012 
MYLIP 2.07 0.000161757 
CCDC117 1.99 0.001246679 
FRMD6 1.88 0.00493782 
NUFIP2 1.77 0.009887267 
DKK1 0.52 0.007441079 
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CHAPTER V 
POL II PAUSING MAINTAINS A BALANCE BETWEEN PRODUCTIVE 
ELONGATION AND PREMATURE TERMINATION DURING 
TRANSCRIPTIONAL RESPONSES 
 
5.1 Turnover of the Paused Pol II Complex is Determined by the Stimulus 
 Escape of paused Pol II into productive elongation is essential in 
producing mRNAs from a gene. The kinase activity of the p-TEFb complex, 
which is composed of the cyclin-dependent kinase CDK9 and Cyclin-T, 
phosphorylates the CTD of the large subunit of Pol II and facilitates the transition 
to productive elongation. During activation of genes, two distinct mechanisms 
come together to increase transcription: increased recruitment of Pol II to 
promoter regions and increased activity of p-TEFb facilitating escape of paused 
Pol II into elongation. Gene activation has been proposed to follow two distinct 
mechanisms in response to E2 and TNF-α in two different cell lines (Danko et al. 
2013). We have previously shown (Samarakkody et al. 2015), as demonstrated 
in chapter 1, that genes can be activated by an increase in recruitment of Pol II 
onto promoter regions without changes in pausing duration. This study 
demonstrated that E2 increases Pol II initiation and TNF-α increases the escape 
of paused Pol II into productive elongation. Although transcriptional activation of 
E2 and TNF-α follows two distinct mechanisms, the inherent differences between 
the two cell lines may have also contributed to the different responses, leaving 
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the question of whether the same gene can be activated through the same 
mechanism open. We next determined whether the response of paused Pol II to 
gene activation is determined by the gene or by the stimulus. To do so, we 
selected genes that are upregulated by both TSA and heat shock in MCF-7 cells. 
If the mechanism of activation is determined by the gene, dynamics of paused 
Pol II and hence the duration of pausing at a given gene will be the same with 
different stimuli. However, if activation of a gene is determined by the stimulus, 
the pause duration of a gene may be different depending upon the stimulus. To 
determine pausing duration, we used Triptolide (TRP), as described in the 
previous chapter, which has been used by us and others to measure pause 
duration (Samarakkody et al. 2015; Henriques et al. 2013) at a final 
concentration of 2.5 μM. We chose to investigate SNAI1 and HSPA1B genes that 
are upregulated both with TSA and heat shock. We first compared how TSA 
treatment affects activation of both SNAI1 and HSPA1B (Figure 11A-D). We 
noted that the pause duration does not change with TSA treatment on both 
tested genes. However, the pause duration is drastically reduced upon heat 
shock treatment on both SNAI1 and HSPA1B (Figure 11E-H) indicating that 
dynamics of the paused complex changes in a stimulus specific manner, and not 
in a gene specific manner. During the heat shock response, the transcription 
factor HSF-1 is known to be recruited to some promoter regions. HSF-1 can 
recruit p-TEFb, a pause release factor. The HSPA1B gene is activated in an 
HSF-1 dependent manner, but SNAI1 is not. The fast decay of Pol II at the pause 
site in HSPA1B can be attributed to pause release that may occur in an HSF-1  
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Figure 11.  Pause duration changes with heat shock and not with TSA 
treatment. Permanganate footprints and quantification plots (right) 
for SNAI1 (A) and (G) and HSPA1B (C) and (E) with TSA and Heat 
shock in the presence of TRP. Each time point is an average of 
3 independent replicates. 
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dependent manner. However, it is yet to be explored whether the rapid decay of 
the paused complex on the SNAI1 gene is due to pause release into elongation. 
5.2 Pol II Turnover Increases Genome wide during Heat Shock Response 
 Knowing that two genes change dynamics of the paused Pol II in the 
presence of heat shock, we next sought to address if it is a characteristic of a 
cohort of upregulated genes, or is common across the genome. To investigate 
Pol II turnover on genes across the genome, we used short capped RNA 
sequencing. With modifications to the published protocol, we selected for short 
capped RNA from the nuclei of MCF-7 cells to investigate genome-wide Pol II 
pausing (Figure 12). Two genes that are known to be paused in MCF-7 cells, 
SNAI1 and CDH1 genes, showed a signal with short-capped RNA sequencing 
(scRNA-seq) while SNAI2, a gene that is not paused at delectable levels in MCF-
7 cells does not (Figure 12). Consistent with what has been previously observed 
in Drosophila and mouse, we observe that Pol II pauses about 35 nucleotides 
downstream of the transcription start site in humans (Figure 13).  
 To select for RNA that results from Pol II pausing, we fractionated cells to 
obtain RNA that is bound to chromatin. Using a previously published protocol, 
(Samarakkody et al., 2015) with modifications, we were able to reliably detect Pol 
II pausing genome-wide using chromatin bound RNA. During the time course 
with TRP the amount of chromatin bound RNA at the 20-minute time point is 
expected to be low to none due to the decay of complexes from the paused site 
(Figure 14). Hence, the libraries from these time points cannot be normalized 
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Figure 12.  Pol II pausing on individual genes. (A). SNAI1 and CDH1 genes 
show evidence of Pol II pausing but (B). SNAI2 gene does not. For 
each gene, a UCSC genome browser view is shown, with positions 
of Pol II ChIP-seq bins and the positions of 5′ and 3′-RNAs 
indicated. For scRNAs, plus and minus strand matches are shown 
as separate tracks. Numbers near each peak represent the 
maximum number of sequence reads within the displayed interval. 
An inset below each gene shows a zoomed-in view of scRNA 
tracks around the TSS. Permanganate footprinting of the same 
gene is shown on the right, alongside naked DNA and A/G ladder. 
Annotated TSSs are shown with arrows and TSS start sites are 
shown in green. The region of permanganate reactivity is shown 
alongside the gel and on the gene scheme in purple. An asterisk at 
the SNAI1 gene indicates a non-specific band present both in cells 
and naked DNA. 
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Figure 13.  (A) Heatmaps showing scRNAs for 7302 genes with the highest 
promoter Pol II enrichment, in the region of ±500 nt around their 
RefSeq (annotated) TSSs. The position of the TSS is shown by an 
arrow. Only the sense strand scRNAs are shown. (B) Metagene 
plot showing the frequency distribution of lengths of scRNAs based 
on distances between R1 and R2 paired-end sequencing read 
positions. 
 
based on the total number of reads. To overcome this, we have used known 
amounts of artificially synthesized short capped RNA, with known lengths and 
sequences, which we added in to Trizol at the step of RNA extraction which are 
then used in normalization.  
 We show that paused Pol II complexes decay in the presence of TRP 
genome-wide as observed for SNAI1 and HSPA1B genes. Secondly, we note 
that most complexes decay faster in the presence of TRP with heat shock 
activation (Figure 15). For genes that are upregulated, the increase in turnover of 
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Figure 14. Chromatin bound RNA allows to detect decay of paused Pol II 
complex genome wide. A HSPA1B and B SNAI1 I genes showing 
decay of signal from R1 reads from scRNA-seq in the presence of 
TRP. 
 
paused complexes can be a result of more pause release in to productive 
elongation to produce more mRNA. Alternatively, the high turnover can also be a 
consequence of increased premature termination which could be especially true 
for genes that are downregulated or not significantly upregulated during 
activation. We also observe that a few genes such as FTL, SNHG1 and RPLP1 
that show increased paused duration upon heat shock.  
5.3 Pause Release by p-TEFb affects Pol II Turnover 
 Having observed that the fast release of paused Pol II is stimulus 
dependent, we sought to answer if pause release completely relies on the activity 
of p-TEFb. We used Flavopiridol (FP), a potent inhibitor of p-TEFb, to investigate 
if paused Pol II complexes are released slower when pause escape is blocked by 
FP. In fact, what we observed was a faster release of paused Pol II at basal 
levels (Figure 16), indicating that the paused complexes may be actively 
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Figure 15. Heat map showing faster decay of complexes genome-wide in the 
presence of TRP. The scale on the left shows the fold change of 
signal and the genes are being ranked after unsupervised 
clustering.  
 
redirected towards premature termination when paused Pol II cannot proceed 
into elongation. Next, we investigated how the dynamics of paused Pol II may 
change during gene activation. Using TSA and heat shock as activators, we 
followed paused Pol II in the presence of FP. We observe that with activation of 
SNAI1 gene with TSA, the complexes showed faster turnover. We compared this 
observation with heat shock activation and noted that the turnover rate of the  
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paused complexes increased in the presence of FP. Hence, for the first time, we 
show that the balance between productive elongation and premature termination 
changes in a stimulus dependent manner.  
 
 
 
Figure 16. Inhibition of p-TEFb with FP shows a stimulus specific effect on 
pausing duration. A. SNAI1 gene showing faster decay in the 
presence of FP along with the quantification plot on the right B. C. 
Gel image for SNAI1 gene in the presence of FP with TSA 
activation with the quantification plot on the right D.
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CHAPTER VI 
DISCUSSION 
 The main objective of this study was to determine how Pol II pausing 
could regulate transcriptional programs in cells in response to stimuli. Pausing 
has been previously suggested to serve as a platform to integrate regulatory 
inputs (Henriques et al. 2013) into a transcriptional outcome. However, the 
mechanisms that involve multiple transcription factors and dedicated proteins in 
regulating transcriptional outcome are not well understood. We demonstrate that, 
firstly, Pol II pausing is retained during activation on genes with both TSA and 
heat shock activation. Secondly, we show that genes can be activated through 
distinct molecular mechanisms primarily through either pause retention or pause 
release. Here, we show that the same gene can be activated by either increase 
in Pol II pausing or by release of pausing depending upon the stimulus. This 
demonstrates that genes are flexible in their response to stimuli and that 
activation of the same gene can occur through distinct molecular mechanisms as 
measured by pause dynamics. Regardless of the mechanism of activation, Pol II 
pausing plays an important role in regulating the transcriptional outcomes.  
 Using global sequencing of scRNA to map Pol II pausing across the 
genome in human MCF-7 breast cancer cells, we show that (i) transcription start 
sites can be reliably detected by analysis of the 5’ ends of scRNA reads and  
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(ii) the location of Pol II pausing can be detected by the 3’ ends. These studies 
show that pausing location is highly conserved across the genomes of different 
classes, Drosophila, mice, and as we show, humans. We note that, consistent 
with what has been observed in other systems, the predominant distance of  
33–35 nucleotides downstream of the TSS was observed across the genome on 
MCF-7 cells, indicating that the underlying molecular mechanisms govern 
pausing of Pol II regardless of the promoter sequence. Furthermore, using the 
scRNA sequencing on RNA from chromatin-bound fraction, we were able to 
detect pause duration on a global scale. We note that most genes show an 
increased turnover at the paused site upon heat shock activation. Future studies 
will determine if genes that demonstrate increased turnover also show increased 
rates of premature termination and pause release upon heat shock as well as 
other stimuli. Monitoring the dynamics of Pol II pausing in response to stimuli will 
be used in future work to for profiling of cells perhaps during differentiation, 
development and also during progression of diseases such as cancers. 
 The work characterizes several novel properties of Pol II pausing. First, 
we demonstrate the plasticity that genes exhibit in response to different stimuli at 
the level of pausing. We show that Pol II pausing continues to provide a stable 
platform not only prior to, but also during transcriptional responses to stimuli. We 
report for the first time that the dynamics of paused Pol II in response to 
activation is not hardwired in the gene, but is dynamically determined by the 
stimulus. Using model genes SNAI1 and HSPA1B, we show that the same gene 
can respond to different stimuli differently and specifically, leading to faster 
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release of paused Pol II with heat shock, yet retention of pausing with TSA. At 
the conditions of fast turnover of Pol II during activation, the location of pausing 
did not change, suggesting that all factors necessary for pause establishment 
and release remain available at the promoter, even at conditions of high-level 
activation. The mechanisms that involve pause release rely on multiple steps of 
p-TEFb recruitment, phosphorylation of NELF, and the interaction or recruitment 
of multiple functions through protein complexes such as the Super Elongation 
Complex. While the interplay between pausing establishment and release across 
the genome remains to be fully understood, our data show that Pol II pausing 
remains the slowest step on heat shock gene in human cells even at the 
conditions of high-level activation. Further analysis of early transcription 
combining nuclear run-on and free RNA-based methods will shed light on the 
mechanisms and global dynamics of pausing during stimulus response. 
 Using several EMT related genes such as SNAI1, CDH1 and SNAI2, we 
show that gene activation can take place without changes in pausing location 
and dynamics as measured by pause duration. Among these genes, SNAI2 is 
considered a non-paused gene due to low levels of promoter Pol II observed in 
cells prior to activation. In addition, SNAI1 and SNAI2 genes are transcribed at 
very low levels in MCF-7 cells. The human SNAI1 gene upon activation with TSA 
acquires pausing signature revealed by increased recruitment of Pol II to the 
promoter. From a perspective of mechanisms, the availability of the negative 
elongation factor (NELF) during each transcription initiation determines the 
establishment of pausing (Gilchrist et al. 2008; Yamaguchi et al. 1999). During 
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differentiation and development, the availability of factors such as NELF may 
change, thus altering pausing status on genes. Overall, we propose that the 
increase of the pausing signal represents the default outcome of gene activation 
that enables context-specific regulatory inputs, one of which is pause release, to 
affect the rate of mRNA synthesis. Further analysis of pausing in different 
systems will uncover its role both in maintaining genes in a “poised” st 
 In Drosophila genes with high levels of Pol II pausing contain initially 
transcribed sequences that favor nucleosomes and promote chromatin 
assembly. In contrast, genes that have low levels of Pol II pausing on promoter 
sequences disfavor nucleosome assembly (Gilchrist et al. 2010). In mammals, 
Pol II pausing is enriched at genes that contain CpG islands at promoter regions 
(Core et al. 2008). Although much debated, there is evidence supporting the idea 
that, as in Drosophila, CG rich mammalian promoters favor nucleosome 
formation, suggesting that pausing at such promoters helps maintain the 
promoter in an open configuration to be readily accessed by the transcription 
machinery. We note that human SNAI2 gene, which is not paused, does not 
contain a CpG island overlapping its promoter, while the paused SNAI1 gene 
does. Although SNAI2 does not contain a CG rich promoter sequence, it is able 
to acquire pausing with increase in recruitment of Pol II. Hence, the presence of 
an overlapping CpG island is not strictly required for pausing, suggesting that 
mechanisms other than DNA methylation, which occurs at CpG islands, may 
control pausing. Further, our finding that TSA upregulates the heat 
shock HSP70 gene independent of the HSF-1 factor suggests that TSA, and 
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HDAC inhibitors in general, can affect genes through bypassing their default 
activation mechanisms including requirement for specific transcription factors. In 
addition, using SNAI1 as an example, we show that genes do not get fully 
occupied by Pol II upon activation. With the use of an artificially synthesized 
bubble template for SNAI1 gene we have determined the relative level of pausing 
in a population of cells. We first note that about 20% of cells contain Pol II 
pausing at basal state on SNAIL gene and that Pol II pausing signal is increased 
by about 2-fold upon activation with TSA. It is likely that most genes, even those 
that are highly paused, are not fully occupied by Pol II, indicating that initiation of 
transcription, and not pausing, may be a rate limiting step in early events of 
transcription of most if not all genes.  
 We note that upon heat shock, HSPA1B is activated through pause 
release in MCF-7 cells. A large fraction of P-TEFb is bound to the 7SK snRNP 
that sequesters the kinase in an inactive state, and another fraction of P-TEFb is 
found in a protein complex known as the Super Elongation Complex (SEC) 
(reviewed in Luo et al 2012). The multiprotein complex of SEC appears to be 
particularly important for rapid induction of transcription in stem cells (Lin et al. 
2011). Although the mechanisms of recruitment of p-TEFb and SEC to gene 
promoters are not completely understood, the mediator subunit MED26 has been 
recently shown to be involved (Takahashi et al. 2011).  
 Most gene promoters contain multiple motifs for binding of transcription 
factors (TF). Among such promoter binding TFs, some assist in recruiting p-TEFb 
to the promoter. BRD4 and cMyc are two of the transcription factors that are 
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largely studied in the context of pause escape. Similarly, HSF-1 has been shown 
to recruit p-TEFb in Drosophila to promote pause release on genes upon heat 
shock activation. Recently, HSF-1 was also shown to regulate pause release in 
mouse cells during heat shock response (Mahat et al. 2016). While the interplay 
between pausing establishment and release remains to be fully understood, our 
data show that Pol II pausing remains the slowest step on heat shock genes in 
human cells even at conditions of high level of gene activation. 
 Recent work showed that Pol II pausing, not the pre-initiation complex, is 
likely the main form of Pol II near promoters in metazoans (Pugh and Venters, 
2016) and our recent analysis of several individual genes supports this notion 
(Samarakkody et al., 2015). Promoters recruit Pol II into a paused site that gets 
distributed into distinct fates of termination versus elongation. While the exact 
factors, and the interplay among factors, remain to be characterized, we suggest 
that termination and pause release into productive elongationcompete during 
transcriptional responses. We suggest that termination does not require P-TEFb 
function (Figure 2). Thus, the fate of the paused complex is not pre-determined 
during transcription initiation, but rather, determined at the paused complex. 
Multiple other factors are involved in pausing and pause release. Some of these 
factors are direct and some are indirect in terms of their effects on Pol II pausing. 
For example, Paf1 may or may not be acting directly. It is clear, however, that Pol 
II pausing emerges as a complex platform for regulatory inputs that enables 
transcriptional signals through multiple mechanisms that remain to be 
investigated.  
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 Cells orchestrate transcriptional responses by rapidly and precisely 
coordinating expression of thousands of genes in a cell type specific manner. 
Unlike single-celled organisms, metazoans are not driven directly by the 
environment, but must follow a predetermined epigenetic program in different 
environmental conditions. Metazoan cells are specialized and must undergo 
responses not only respond to the signal, but also must stay within their 
epigenetically specified programs. Evolutionary advantages have given 
metazoans numerous means of retaining their epigenetic identity in the presence 
of stress conditions, which is essential in survival of the organism. Because only 
a small number of genes respond directly to the stimulus, additional mechanisms 
must be involved in global transcriptional responses. How transcriptional 
machinery is “primed” for transcriptional responses remains largely unclear. The 
phenomenon of transcriptional pausing is a key regulatory mechanism that has 
received much attention due to its prevalence in early response genes and its 
association with important regulatory process such as cell differentiation, 
development, and responses to stimuli. Although the duration of the paused 
complex is known to change during responses to stimuli, how Pol II pausing 
changes during transcriptional responses remains to be investigated in the 
future. It is not clear whether activation of genes must require release of paused 
Pol II, or if transcriptional events lead to a decrease in pausing duration. Here we 
demonstrate that not only levels of Pol II pausing, but pause duration are 
measures of the state of a gene. The availability of factors that regulate Pol II 
pausing in promoter proximal regions may play a determining role in how genes 
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would respond to stimuli. For instance, cMyc that plays a role in promoter 
proximal regions has been shown to be overexpressed in cancer cells. Perhaps 
the dysregulation of genes during disease conditions may occur at the levels of 
transcription at the paused site. 
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APPENDIX A 
ABBREVIATIONS 
7-mG cap 7-methylguanosine cap 
ATP Adenosine triphosphate 
CBC Cap Binding Complex 
CBP Cap Binding Protein 
CDK Cyclin-dependent Kinase 
ChIP Chromatin Immunoprecipitation 
ChIP-seq Chromatin Immunoprecipitation sequencing 
CPSF cleavage and polyadenylation specificity factor  
CTD Carboxyl-Terminal Domain 
DNA Deoxyribonucleic Acid 
DRB 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole  
DSIF (DRB) Sensitivity-Inducing Factor 
E2 17β-Estradiol  
EMT Epethelial to Mesenchymal Transition 
FACT Facilitates Chromatin Transcription  
FP Flavapiridol 
GRO Global Run-on 
GRO-seq Global Run-on-sequencing 
GTF General Transcription Factors 
GTP Guanosine triphosphate 
HIV Human Influenza Virus 
HSE Heat Shock Element 
HSF Heat Shock Facor 
HSP70 Heat Shock Protein 70 
HSR Heat Shock Response 
IL-8 Interleukin-8 
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MAPK Mitogen-Activated Protein Kinase  
mG cap methylguanosine 
min minutes 
mRNA messenger RNA 
NELF Negative Elongation Factor 
NF-κB Neclear Factor Kappa Beta 
nt nucleotide 
PAF Polymerase II Asssociated Factor 
PCF11 Cleavage and Polyadenylation Factor subunit 
PCR Polymerase Chain Reaction 
PI3K Phosphoinositide 3-kinase 
PIC Pre-initiation Complex 
Pol II RNA Polymerase II 
Pro-seq Precision nuclear run-on sequencing 
p-TEFb Positive Transcription Elongation Factor 
RNA Ribonucleic Acid 
RT Reverse Transcription 
RT-PCR Reverse Transcription- Polymerase Chain Reaction 
SAM S-adenosylmethionine 
scRNA Short capped RNA 
scRNA-seq Short capped RNA sequencing 
snRNP small nuclear ribonucleic proteins  
TES Transcription End Site 
TF Transcription Factor 
TNF-α  Tumor Necrosis Factor alpha 
TRP Triptolide 
TSA Trichostatin A 
TSS Transcription Start Site 
TTF Transcription termination Factor 
XRN-2 5'-3' exoribonuclease 2 
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APPENDIX B 
LIST OF PRIMERS  
hCDH1+272A tttcttggaagaagggaag 
hCDH1+272B ttcttggaagaagggaagc 
hCDH1+272C agaagggaagcggtgacgac 
hSnail+210A caatggtccacaaaacatc 
hSnail+210B acatcctgtgactcgatcct 
hSnail+210C tgtctcccccaaacctcctg 
hSlug+225A tttgcaaagctctagatacg 
hSlug+225B tgtccagttcgctgtagttt 
hSlug+225C ggctttttggaggcgttgaa 
mSnail+259A agctccagatccacctgt 
mSnail+259B gctccagatccacctgtc 
mSnail+259C gcagagcccgattctcacct 
 
 
  
  
  
 
 
 
 
